Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Capmatinib Approved in Japan for METex14-Altered Advanced NSCLC

OncLive - The Japanese Ministry of Health, Labor, and Welfare has approved capmatinib for patients with MET exon 14 skipping mutation–positive advanced and/or recurrent unresectable non–small cell lung cancer.

Read the full article here